Why Psychiatric Drug Development Is Losing Momentum

Producción científica: Editorial › revisión exhaustiva

Idioma original	English (US)
Páginas (desde-hasta)	iii-v
Publicación	Current Psychiatry Research and Reviews
Volumen	22
N.º	1
DOI	https://doi.org/10.2174/0126660822454711251028043910
Estado	Published - 2026

ASJC Scopus subject areas

@article{3e0204804b934381aa61e42122562186,

title = "Why Psychiatric Drug Development Is Losing Momentum",

author = "Rajendra Badgaiyan",

year = "2026",

doi = "10.2174/0126660822454711251028043910",

language = "English (US)",

volume = "22",

pages = "iii--v",

journal = "Current Psychiatry Research and Reviews",

issn = "2666-0822",

publisher = "Bentham Science Publishers",

number = "1",

}

TY - JOUR

T1 - Why Psychiatric Drug Development Is Losing Momentum

AU - Badgaiyan, Rajendra

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105021420539

UR - https://www.scopus.com/pages/publications/105021420539#tab=citedBy

U2 - 10.2174/0126660822454711251028043910

DO - 10.2174/0126660822454711251028043910

M3 - Editorial

AN - SCOPUS:105021420539

SN - 2666-0822

VL - 22

SP - iii-v

JO - Current Psychiatry Research and Reviews

JF - Current Psychiatry Research and Reviews

IS - 1

ER -